NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-155-2001-0-PCT-02 Cyr61 as a Biomarker / Clinical Laboratory Test / Treatment For Acute Renal Failure PCT PCT PCT/US03/009187 Abandoned
NINDS E-084-2003-0-US-01 Identification, quantification, and characterization of T cells and T cell antigens US 60/457,006 Abandoned
NCI E-002-2002-1-PCT-01 Material And Methods For Inhibiting WIP-1 PCT PCT COMB PCT/US03/08997 Expired
NIDDK E-185-2000-0-US-03 Identification of The Dombrock Blood Group Glycoprotein As A Polymorphic Member of The ADP-Ribosyltransferase Gene Family US National Stage 10/381,325 Abandoned
NHLBI E-014-2003-0-US-01 Spiral Tube Support For Countercurrent Chromatography US 60/457,058 Abandoned
NCI E-193-1997-0-US-04 RECOMBINANT ADENOVIRAL TARGETING VECTOR US DIV 10/393,694 Abandoned
NIA E-087-2000-0-US-03 ESTABLISHMENT OF CELLULAR MANIPULATIONS WHICH ENCHANCE OLIGO-MEDIATED GENE TARGETING US National Stage 10/239,595 7358090 Abandoned PDF
NIA E-183-2003-0-KR-13 Method For Treating Cognitve Disorders KR National Stage 10-2004-7014635 Abandoned
NIA E-183-2003-0-AU-04 Method For Treating Cognitve Disorders AU National Stage 2003230683 Abandoned
NIA E-183-2003-0-PCT-03 Method For Treating Cognitve Disorders PCT PCT PCT/US03/08407 Expired
NIEHS E-105-2002-0-PCT-02 REGULATION OF INS (3456) P4SIGNALLING BE A REVERSIBLE KINASE/ PHOSPHATASE AND METHODS AND COMPOSITIONS RELATED THERETO PCT PCT PCT/US03/08641 Expired
NIA E-183-2003-0-EP-08 Method For Treating Cognitve Disorders EP National Stage 03723773.2 Abandoned
NIA E-183-2003-0-BR-05 Method For Treating Cognitve Disorders BR National Stage PI0306855-2 Abandoned
NIA E-183-2003-0-CA-06 Method For Treating Cognitve Disorders CA National Stage 2476923 Abandoned
NIA E-183-2003-0-PL-17 Method For Treating Cognitve Disorders PL National Stage P372315 Abandoned
NIA E-183-2003-0-IL-10 Method For Treating Cognitve Disorders IL National Stage 163993 Abandoned
NIA E-183-2003-0-IN-11 Method For Treating Cognitve Disorders IN National Stage 2586/DELNP/2004 Abandoned
NCI E-194-2000-0-US-03 Viral Chemokine-antigen Fusion Proteins US National Stage 10/380,927 7897152 Abandoned PDF
NCI E-196-2000-0-US-03 Defensin-Antigen Fusion Proteins US National Stage 10/380,926 7754676 Abandoned PDF
NCI E-208-2002-0-US-01 Applications of the HMGN1 Pathway US 60/455,728 Abandoned
NCI E-097-2003-0-US-01 TLT-1, a novel inhibitory receptor and uses thereof US 60/455,370 Abandoned
NCI E-115-2003-0-US-01 Programmed Probabilistic Gene Expression Mediated By An Overlapping Bi-Directional Promoter US 60/455,068 Abandoned
NHGRI E-167-2001-2-EP-05 Hepatocyte growth factor (HGF) and/or insulin-like growth factor-1 (IGF-1) for use in myocardial regeneration EP National Stage 03716535.4 Expired
NIA E-183-2003-0-US-02 Method For Treating Cognitve Disorders US ORD 10/386,915 Abandoned
NCI E-087-2003-0-US-01 ABCA13 Nucleic Acids and Proteins, and Uses Thereof US 60/454,502 Abandoned
NHGRI E-167-2001-2-PCT-02 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium PCT PCT PCT/US2003/007731 Expired
NHGRI E-167-2001-2-IL-03 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium IL National Stage 165560 Expired
NHGRI E-167-2001-2-CN-07 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium CN National Stage 3818704.3 Expired
NHGRI E-167-2001-2-JP-04 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium JP National Stage 2004510732 Expired
NCI E-321-2000-0-US-02 Antisense Oligonucleotides Targeting Folate Receptor Alpha, And the Use Thereof US ORD 10/093,523 7030236 Abandoned PDF
NINDS E-177-1999-2-US-02 A System and Method for Identifying T Cell Epitopes US National Stage 10/380,147 Abandoned
NCI E-328-2002-0-US-01 Synthesis of Proteins by Cell-Free Protein Expression US 60/454,013 Abandoned
NCI E-049-2003-0-US-01 Apparatus and Process for Dose-Guided Radiotherapy US 60/453,934 Abandoned
NIAID E-232-2004-4-EP-11 Compositions And Methods For Generating An Immune Response EP DIV 10184784.6 Expired
NIAID E-232-2004-4-CA-05 Compositions And Methods For Generating An Immune Response CA National Stage 2478371 Expired
NIAID E-232-2004-4-IN-06 Compositions And Methods For Generating An Immune Response IN National Stage 2623/DELNP/2004 Expired
NIAID E-232-2004-4-AU-04 Compositions And Methods For Generating An Immune Response AU National Stage 2003220111 Expired
NIAID E-232-2004-4-PCT-02 Compositions And Methods For Generating An Immune Response PCT PCT PCT/US2003/007177 Expired
NCI E-131-2000-0-US-06 Methods For Reducing Tumor Growth and Metastasis by Inhibiting MCP-1 Activity US National Stage 10/276,644 Abandoned
NIAID E-232-2004-4-CN-03 Compositions And Methods For Generating An Immune Response CN National Stage 03810451.2 Expired
NIAID E-232-2004-4-JP-08 Compositions And Methods For Generating An Immune Response JP National Stage 2003-574798 Expired
NIAID E-232-2004-2-JP-06 DNA expression vectors and methods of use JP National Stage 2002-500664 Expired
NIAID E-232-2004-4-EP-07 Compositions And Methods For Generating An Immune Response EP National Stage 03716404.3 Abandoned
NCI E-039-2003-0-US-01 Combinatorial Therapy for Protein Signaling Diseases US 60/453,629 Abandoned
NIDCR E-160-2000-0-US-11 Method for identifying compounds modulating taste transduction US CON 10/383,982 7479373 Expired PDF
NCI E-225-2002-0-US-01 Chromatographic Purification of Single-Chain, Variable-Region Anti-HER2/neu Antibody US 60/452,539 Abandoned
NIEHS E-314-2002-0-US-01 Regulation of RNA stability US 60/451,976 Abandoned
NCI E-302-2000-2-NZ-07 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway: A Selective Therapeutic Strategy Against Melanoma NZ National Stage 524636 Abandoned
NHGRI E-018-1997-0-US-08 AIB1, A NOVEL STEROID RECEPTOR CO-ACTIVATOR US DIV 10/379,616 7232890 Abandoned PDF
NCI E-220-2009-0-CA-03 Polynucleotide Sequences of Viruses Associated with Lymphadenopathy Syndrome and/or Acquired Immune Deficiency Syndrome05 CA DIV 1341482 Expired